Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2017 01/12/2017 01/13/2017 01/17/2017 01/18/2017 Date
162.35(c) 162.84(c) 162.57(c) 160.47(c) 161.23(c) Last
2 487 581 1 499 806 1 115 230 1 186 475 1 012 048 Volume
-1.63% +0.30% -0.17% -1.29% +0.47% Change
More quotes
Financials ($)
Sales 2016 2 396 M
EBIT 2016 670 M
Net income 2016 438 M
Finance 2016 416 M
Yield 2016 -
Sales 2017 2 650 M
EBIT 2017 731 M
Net income 2017 481 M
Finance 2017 696 M
Yield 2017 -
P/E ratio 2016 54,08
P/E ratio 2017 48,98
EV / Sales2016 9,66x
EV / Sales2017 8,63x
Capitalization 23 573 M
More Financials
Company
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function.The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing... 
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
01/17 ILLUMINA : to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on ..
01/17 ILLUMINA, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
01/16 ILLUMINA, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
01/12 ILLUMINA, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
01/12 ILLUMINA : NRGene Collaborate to Accelerate Development of New Molecular Breedin..
01/11 ILLUMINA, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
01/11 ILLUMINA INC : Results of Operations and Financial Condition, Amendments to Arti..
01/11 BIOTECH MOVERS : Illumina, Inc. (NASDAQ:ILMN) and EnteroMedics Inc (NASDAQ:ETRM)
01/11 IBM INTERNATIONAL BUSINESS MACHINES : IBM and Illumina Partner to Standardize G..
01/11 ILLUMINA, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
2016 EXCLUSIVE : U.S. regulator poised to approve Abbott purchase of St Jude - source..
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA, INC. 
2015We anticipate a reversal
2013End of the technical recovery
More Strategies
Latest Tweets
01/17IBM Watson Health and Illumina team up on cancer research
2
01/17Illumina Release: Company To Announce Fourth Quarter And Fiscal Year 2016 Fin.. 
01/17Illumina : to Announce Fourth Quarter and Fiscal Year 2016 Financial Results .. 
01/17How #Illumina plans to change medicine forever
2
01/16How Illumina Plans to Change Medicine Forever: Motley Fool  
More tweets
Qtime:94
News from SeekingAlpha
01/11 BIOTECH FORUM DAILY DIGEST : Keytruda Continues To Power Merck; Revisiting Invit..
01/10 BIOTECH FORUM DAILY DIGEST : Biotech Continues To Rally. Revisiting Merrimack Ph..
01/10 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
01/10 Illumina up 15% premarket on launch single-cell gene sequencer
01/09 Illumina introduces new DNA sequencer that could enable a $100 genome
Advertisement
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 146 $
Spread / Average Target -9,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Norman Fjeldheim Chief Information Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.25.33%23 573
THERMO FISHER SCIENTIF..2.80%57 298
DANAHER CORPORATION3.94%55 966
BOSTON SCIENTIFIC CORP..10.49%32 544
PHILIPS-2.64%28 034
INTUITIVE SURGICAL, IN..4.66%25 718
More Results